Rights & Society
EMA Issues Guidance on Clinical Trials
The Accelerating Clinical Trials in the EU (ACT EU) initiative, under the European Medicines Agency (EMA), published draft guidance on conducting clinical trials during public health emergencies. The document details how to maintain trial integrity and participant safety during crises. It addresses adaptive trial designs and data management. The guidance aims to improve preparedness and ensure continued research during emergencies.
New EU guidance aims to improve clinical trial conduct during health crises.